= RXC
:render_as: Level3
:v291_section: 4A.4.3

If the drug or treatment ordered with the RXO segment is a compound drug OR an IV solution, AND there is not a coded value for _OBR-4-universal service ID_, which specifies the components (base and all additives), then the components (the base and additives) are specified by two or more RXC segments. The policy of the pharmacy or treatment application on substitutions at the RXC level is identical to that for the RXO level.

HL7 Attribute Table – RXC – Pharmacy/Treatment Component Order

[width="100%",cols="14%,6%,7%,6%,6%,6%,7%,7%,41%",options="header",]

|===

|SEQ |LEN |C.LEN |DT |OPT |RP/# |TBL# |ITEM # |ELEMENT NAME

|1 |1..1 | |ID |R | |file:///E:\V2\v2.9%20final%20Nov%20from%20Frank\V29_CH02C_Tables.docx#HL70166[0166] |00313 |RX Component Type

|2 | | |CWE |R | |file:///E:\V2\v2.9%20final%20Nov%20from%20Frank\V29_CH02C_Tables.docx#HL70697[0697] |00314 |Component Code

|3 | | |NM |R | | |00315 |Component Amount

|4 | | |CWE |R | |file:///E:\V2\v2.9%20final%20Nov%20from%20Frank\V29_CH02C_Tables.docx#HL70698[0698] |00316 |Component Units

|5 | | |NM |O | | |01124 |Component Strength

|6 | | |CWE |O | |file:///E:\V2\v2.9%20final%20Nov%20from%20Frank\V29_CH02C_Tables.docx#HL70699[0699] |01125 |Component Strength Units

|7 | | |CWE |O |Y |file:///E:\V2\v2.9%20final%20Nov%20from%20Frank\V29_CH02C_Tables.docx#HL70700[0700] |01476 |Supplementary Code

|8 | |5# |NM |O | | |01671 |Component Drug Strength Volume

|9 | | |CWE |O | |file:///E:\V2\v2.9%20final%20Nov%20from%20Frank\V29_CH02C_Tables.docx#HL70701[0701] |01672 |Component Drug Strength Volume Units

|10 | | |NM |C | | |03314 |Dispense Amount

|11 | | |CWE |C | |file:///E:\V2\v2.9%20final%20Nov%20from%20Frank\V29_CH02C_Tables.docx#HL70703[0703] |03315 |Dispense Units

|===

